Shares of Veradermics, Incorporated (MANE) are surging about 44 percent during Monday morning trading after the company announced positive topline results in the Phase 2/3 trial for VDPHL01, an oral formulation of minoxidil for treating male pattern hair loss.
The company's shares are currently trading at $97.67 on the New York Stock Exchange, up 44.18 percent. The stock opened at $81.07 and has climbed as high as $101.81 so far in today's session. Over the past year, it has traded in a range of $32.00 to $101.81.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.